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Abstract
Background: The aim of this study was to evaluate salivary alpha-amylase (sAA), considered a non-invasive
biomarker for sympathetic nervous system (SNS) activity, and salivary cortisol as possible pain-induced stress
biomarker, in horses with acute abdominal disease. Therefore, a prospective observational study was performed in
which both biomarkers were analyzed in a group of horses with acute abdomen syndrome, and compared with a
group of healthy control horses by an unpaired Student’s t-test. In addition, the possible relationship between both
biomarkers, the score in Equine Acute Abdominal Pain scales version 1 (EAAPS-1 scale), Heart Rate (HR) and
Respiratory Rate (RR), plasma lactate, the systemic inflammatory response syndrome (SIRS) score and serum amyloid
A (SAA) concentration was assessed by a Spearman correlation test.
Results: A total of 30 horses were included in the study, 19 with acute abdominal disease diagnosed as large colon
displacements, simple impactions of the pelvic flexure, spasmodic colics and enteritis and 11 healthy ones. sAA
activity (24.5 median-fold, P < 0.0001) and salivary cortisol (1.7 median-fold, P < 0.01) were significantly higher in
horses with acute abdomen than in healthy horses. sAA activity was significantly correlated with EAAPS-1 scale (r = 0.78,
95% confidence interval [CI] 0.38–0.89, P < 0.001) and SIRS score (r = 0.49, 95% CI 0.03–0.78, P < 0.05). Neither sAA nor
salivary cortisol correlated with HR, RR, plasma lactate and SAA.
Conclusions: Although this study should be considered as preliminary one, alpha-amylase measurements in saliva could
be a biomarker of pain-induced stress in horses with acute abdominal disease.
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Background
Equine acute abdominal disease is one of the most im-
portant and relatively frequent diseases found in horses
[1], being associated with different degrees of pain [2].
Currently, different scales have been developed for clin-
ical use to evaluate the pain in the acute abdominal dis-
ease in horses such as the Equine Utrecht University
Scale for Composite Pain Assessment (EQUUS-COM-
PASS) [1], the Equine Utrecht University Scale for Facial
Assessment of Pain (EQUUS-FAP) [1], and the Equine
Acute Abdominal Pain scales (EAAPS, version 1 and 2)
[3]. In addition, physiological and endocrine measure-
ments, such as heart (HR) and respiratory rate (RR), and
blood catecholamines and cortisol levels have been used
to assess pain in horses [4–6].
Saliva sampling is easy to obtain, non-invasive and less
stressful than blood sampling [7]. Therefore, saliva
would be an adequate sample for evaluating possible
pain-induced stress level since reflects the activity of the
sympathetic adrenal medullary system in individuals
under stress. Plasma cortisol concentrations have a posi-
tive correlation with pain in horses [6] and a high correl-
ation coefficient between blood and salivary cortisol* Correspondence: ftecles@um.es
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concentrations has been found in horses [8]. Salivary
alpha amylase (sAA) is considered as non-invasive bio-
marker for sympathetic nervous system (SNS) activity
[9] and increases in psychological and physical stress sit-
uations [9, 10]. Previous reports have indicated the po-
tential of sAA as an indirect marker for pain in mice [7].
In addition, sAA has been used in horses as a stress bio-
marker in different situations of physical efforts such as
walking, trotting and dressage exercises [11]. So it could
be postulated that measuring biomarkers like sAA or
salivary cortisol can give a more reproducible method
and objective assessment of pain-induced stress level in
horses to contribute to an integrated description of state
of pain. However, to the authors` knowledge, sAA activ-
ity and salivary cortisol have not been evaluated in
equine acute abdominal disease.
The main objective of this study was to evaluate sAA
activity and salivary cortisol in horses with acute abdom-
inal disease as pain-induced stress biomarkers. For this
purpose, a prospective observational study was designed
in which sAA and salivary cortisol were analyzed in a
group of horses with acute abdomen syndrome, and the
possible changes in both biomarkers depending of the
pain degree evaluated by the EAAPS-1 scale were stud-
ied. In addition, possible relationships between these sal-
ivary biomarkers, physiological variables such as HR and
RR, the severity of the process evaluated by plasma lac-
tate and the systemic inflammatory response syndrome
(SIRS) score [12] and also the inflammation evaluated by
serum amyloid A (SAA) concentration were assessed.
Methods
Stability pilot study
To evaluate sAA and salivary cortisol stability at room
temperature and in refrigeration, a pilot study was per-
formed. Saliva from five horses with different levels of
sAA (ranging from 15.5 U/L to 59.1 U/L) and saliva cor-
tisol (ranging from 0.17 μg/dL to 0.71 μg/dL) were se-
lected. From each sample two aliquots were made: one
was kept at room temperature (25 °C) and the second
one was refrigerated (4 °C). Measurements were made
just after saliva collection, 24 h and 48 h later.
Clinical case and control population
The diseased population included private owned horses of
two different provinces of Spain (Almería and Granada)
showing abdominal pain that required the visit of a veter-
inarian and that were diagnosed as acute abdominal dis-
ease. Horses were evaluated by two veterinary specialists
in equine clinic who visited the horses at their boxes. In-
formation about age, gender, breed, treatment before pres-
entation, heart rate, respiratory rate, pounding digital
pulses and capillary refill time was collected. The clinical
diagnosis was based on history, physical examination
(abdominal auscultation, rectal examination and nasogas-
tric intubation) and the results of additional diagnostics
tests: (1) complete blood work by complete blood count
(CBC) including hematocrit value (HCT), hemoglobin
concentration, erythrocyte indices, platelet count, white
blood cell (WBC) and differential WBC counts; (2) chem-
istry profile including plasma lactate and SAA; (3) abdom-
inal ultrasound; (4) and abdominocentesis if it was
necessary. Horses with pounding digital pulses or lame-
ness that could indicate laminitis or synovitis [2] were not
included in the study.
Eleven privately owned horses of the same provinces
were selected as control group for being healthy based
on history, physical examination, and a lack of abnor-
malities on CBC and serum biochemistry profile. Four
females, two geldings and five stallions integrated this
group, with a mean age of nine years (range of 2–15).
The breeds included were six Spanish and five crossbred
horses.
Sampling
The samples collection was taken at the time of the vet-
erinarian examination of the horse. In addition, sample
collection was obtained before any potentially painful
procedures (jugular venipuncture, nasogastric intub-
ation, etc.).
Saliva samples were collected by introducing a small
sponge in the horses’ mouth for at least 1 min, and they
were placed in collection devices (Salivette, Sarstedt,
Aktiengesellschaft & Co). Blood samples were collected
after saliva sampling by jugular venipuncture. Saliva
and blood were centrifuged at 4000 g for 8 min at 4 °C
and then transferred into 1.5 mL eppendorf tubes and
stored at − 80 °C until analysis. Saliva and blood sam-
ples were referred in refrigeration to Interdisciplinary
Laboratory of Clinical Analysis of UMU (Interlab-
UMU) after 24–48 h. Horses that yielded serum sam-
ples with gross hemolysis and blood contaminated
saliva samples were excluded from the study. No
treatment was administered to the horses before the
sample collection.
Pain behavior scale
EAAPS-1 [3, 13] was evaluated in the habitual box of
the horses with a previously history of abdominal pain
by the veterinarians immediately upon arrival and before
sample collection. This is based on a 5 point-score,
which grades the severity of pain the horse is showing
by picking the most severe behavior manifested, and the
score for that particular behavior is the pain score
(Table 1). Pain scale was translated to Spanish language
and it was described in detail to the veterinarians before
the beginning of the experimental study.
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Assays for salivary biomarkers
sAA activity was measured using a colorimetric com-
mercial kit (Alpha-Amylase, Beckman Coulter Inc.) fol-
lowing the International Medicine (IFCC) method [14],
as previously reported and validated for horses [11], in
an automatic analyser for biochemical assay (Olympus
UA600, Olympus Diagnostica GmbH). It was expressed
as U/L.
Salivary cortisol was analyzed with an immunoassay
system (Immulite 1000, Siemens Healthcare Diagnostic),
which uses a solid-phase competitive enzyme-amplified
chemiluminescent immunoassay. The assay showed an
intra-assay coefficient of variation lower than 15%, a par-
allel displacement to the standard linearly curve with
serial sample dilutions and a analytical limit of detection
of 0.016 μg/dL [15].
Statistical analysis
The statistical analyses were calculated using Graph Pad
Prism 6 (Graph Pad Software). sAA activity and salivary
cortisol concentration results, EAAPS-1 score, HR and
RR, plasma lactate concentration and SAA concentra-
tion were checked using Shapiro-Wilk test to assess nor-
mality, showing all of them a non-normal distribution
except plasma lactate. Then, sAA and salivary cortisol
results were transformed logarithmically by applying the
formula ln x = ln (x + 1) [16] that restored normality be-
fore a unpaired Student’s t test (2-tailed) to determine if
sAA and salivary cortisol were statistically different be-
tween clinical cases and controls.
The minimum number of individuals necessary to be
included in each group for reaching a significance level
of α = 5% (P < 0.05) and a power of 80% was calculated.
For this purpose, means and standard deviations were
initially calculated for the first 11 individuals received
from the clinical cases and for the 11 control horses,
and a stand-alone power programme for statistical
testing commonly used in social and behavior research
(G-Power) [17] was employed. This gave that a mini-
mum number of seven individuals for each group get ap-
propriate results for sAA and salivary cortisol. However,
a post hoc analysis was performed with the final number
of animals used in the study to guarantee that the sig-
nificance level and power required were correctly
obtained.
Additionally, a Spearman correlation between salivary
biomarkers (sAA and salivary cortisol), pain scale, HR,
RR, plasma lactate, the systemic inflammatory response
syndrome (SIRS) score and SAA was performed. The
SIRS is defined as having two or more abnormal results
for any of the following: HR > 52 beats/min, RR > 20
breath /min, WBC above or below 5.0–12.5 × 109/L, and
temperature below or above 37.0–38.5 °C [12]. SIRS
score is obtained on the number of abnormal SIRS
criteria (4 point-score).
To study the stability of the salivary analytes mea-
sured, a repeated measures ANOVA and the Friedman
post hoc test were used to evaluate changes in mean
sAA and salivary cortisol in five saliva samples after stor-
age at room temperature (25 °C) and refrigeration (4 °C)
for 48 h. The limit for considering an acceptable stability
for a given storage conditions was set as differences in
values between time points lower than two intra-assay
coefficient of variation (CV) of the assays (7.2% × 2 = 14.
4% for sAA; and 12.5% × 2 = 25.1% for salivary cortisol)
and no significant (P < 0.05) differences over time in
relation to baselines levels (just after collection) [18].
Results
Clinical cases
Nineteen animals were included in the group of horses
with acute abdominal pain, being seven females, four
geldings and eight stallions. Average age was eight years
(range of 1–19). The breeds included were nine Spanish
horses, one Friesian horse, and nine were crossbred
horses. Causes of the acute colic were diagnosed as large
colon displacements (n = 10), simple impactions of the
pelvic flexure (n = 5), spasmodic colics (n = 3) and enter-
itis (n = 1). All horses received medical treatment, since
to the judgment of the clinicians it was considered more
convenient. Of the 19 clinical cases, 17 survived while
two horses with colon displacements died due to the
disease. The two horses that did not survive showed
the highest plasma lactate and SAA concentrations
(one 18.08 mmol/L and 213.1 μg/mL, and the other
19.09 mmol/L and 308.5 μg/mL, respectively). Indi-
vidual values about data required for the SIRS score
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calculation (HR, RR, temperature and WBC) in the
disease horses are reported in the Additional file 1.
sAA and salivary cortisol in acute colic
The five saliva samples used in the pilot stability study
did not show significant changes in their sAA and saliv-
ary cortisol values at 24 and 48 h of storage compared
with baseline values. In addition, the values obtained be-
tween the different time points did not differ more than
two times the intra-assay CV.
Median and quartiles values of sAA and cortisol ap-
pear in Fig. 1. Salivary cortisol was measured in 27
horses (16 of the acute abdomen group and 11 of the
control group) due to insufficient saliva volume. sAA ac-
tivity (U/L) in horses with acute abdomen was signifi-
cantly higher than in healthy control horses (24.5
median-fold, t25.44 = 7.27, P < 0.0001). Salivary cortisol
was also significantly higher in horses with acute colic
than in healthy controls (1.7 median- fold, t21.54 = 3.43,
P < 0.01). The highest values of sAA (706.7 U/L and
680.9 U/L) and salivary cortisol (2.9 μg/dL and 1.3 μg/dL)
were presented in the two no-survivor horses. The post
hoc analysis performed with the final number of individ-
uals used in this study computed a power of 90% for the
sAA results and 89% for salivary cortisol results.
Correlation between parameters
Coefficients of correlation between salivary biomarkers
and pain scale, HR, RR, plasma lactate, SIRS score, SAA
and salivary flow rate are shown in Table 2. A significant
correlation between sAA activity and pain scale was
observed (n = 19, r = 0.78, 95% confidence interval
[CI] 0.38–0.89, P < 0.001), while salivary cortisol did
not correlate with pain scale (Table 2). In addition,
sAA activity was also correlated with SIRS score (n =
19, r = 0.49, 95% CI 0.03–0.78, P < 0.05). Both salivary
biomarkers did not correlate between them, neither
with plasma lactate or SAA.
Discussion
In veterinary practice, adequate diagnosis and treatment
of painful conditions is dependent on accurate recogni-
tion of pain experienced by non-verbal animals [2], and
represent an important way to improve the welfare and
quality of care of the equine patient [19]. In horses, tools
for objective assessment of pain such as cardiovascular
measurements (HR and blood pressure) or biochemical
determinations of plasma concentrations of β-
endorphins, catecholamines and corticosteroids have
been used for this purpose [1, 20]. In addition different
scales based on external signs have been used to evaluate
pain in horses; in this study EAAPS-1 scale was used be-
cause it is faster and easier to assess than EQUUS-
COMPASS and EQUUS-FAP scales, being EAAPS-1
more reliable than EAAPS-2.
sAA activity was evaluated in our work as a potential
indirect marker of pain showing a good correlation with
EAAPS-1 and higher values in horses with acute abdom-
inal disease compared to controls. Although compari-
sons should be made with caution due to the different
species and nature of pain, the correlation found in our
work was higher than those described in previous stud-
ies in humans such as heat pain perception [21], cancer
with bone metastases [22] and chronic pain [23]. In
addition, the magnitude of the increases of sAA found in
colic cases compared to control group (24.5 median-fold)
was higher than when pain was induced in mice (3.5
mean-fold) [7]. Overall, based in our results, it could be
postulated that there is relation between pain and higher
levels of sAA activity in horses with acute abdomen syn-
drome. Although further studies should be made to cor-
roborate this, a possible cause of increasing of sAA would
be the activation of SNS caused by pain [24]. No
Fig. 1 Salivary alpha-amylase (sAA) activity (a) and salivary cortisol
(b) from horses with acute abdominal pain (cases) and healthy horses
(controls). The plot shows median (line within box), 25th and
75th percentiles (box), 5th and 95th percentiles (whiskers) and
outliers (•). The cross inside the box shows the mean. Asterisk indicates
statistically significant difference (**P < 0.01; **** P < 0.0001)
between groups
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correlations were found between sAA and HR or RR.
Although these parameters may be affected by pain
and are often incorporated into composite pain scales
as physiological parameters [2], several studies re-
ported that, in general, physiological parameters are
weakly associated with pain [4, 25, 26].
sAA was not correlated with plasma lactate and SAA,
which are considered as markers of severity of disease
[5] and acute inflammation in horses [27], as was mod-
erately correlated with SIRS score. Overall this data
would indicate that sAA is more linked with pain that
with the inflammation that occurs in the cases of acute
abdominal pain. Salivary cortisol did not correlate with
pain scales in this preliminary study, although horses
with colic showed higher values of cortisol than the
healthy ones. However, previous reports showed a cor-
relation between blood cortisol and a composite multi-
factorial pain scale (CPS) in acute orthopedic pain in
horses [28]. Maybe the different nature of the pain
stimulus could be the reason of this discrepancy. In
addition, salivary cortisol did not correlate with sAA.
The absence of correlation between sAA and salivary
cortisol has been previously described [11, 29, 30]. One
reason for this lack of correlation could be that sAA re-
flects the reaction of the SNS, while cortisol is related
with the hypothalamic -pituitary-adrenal (HPA) axis [31,
32] having a different time of response, with the sAA re-
lease being faster than the cortisol. In all cases of our
study, the colic were acute because they lasted lower
than one day and the veterinarian attended the case as
an emergency [33, 34], therefore it could be postulated
that in some cases the cortisol could not reach its peak
of concentration.
The pilot study made about sampling storage sug-
gested that sAA activity and salivary cortisol were stable
with the handling conditions of the saliva samples used
in our study. Stability of the analyte is an important
point when saliva is used as a sample since significant
changes in concentrations can appear in some analytes
under specific storage conditions, such as occurs with
Norepinephrine in saliva after storage at 25 °C more
than one hour [35].
This study has various limitations. One could be re-
lated with the accuracy of evaluation of the pain by the
EAAPS-1 scale. Although EAAPS-1 was described in de-
tail to the veterinarians before the study started and Sut-
ton et al. [3] reported a good inter-rater reliability when
scale was validated, it is important to point out that
there are no standardized pain scale yet to assess the
horses’ pain. Other limitation is that, although horses
with possible laminitis or synovitis were excluded from
the study, other possible pain diseases that could influ-
ence sAA values were not controlled, such as oral
wounds [36]. In addition, the results of this study could
not be extrapolated to situations of pain produced by
other diseases such as laminitis or synovitis, and specific
studies to evaluate the dynamics of both salivary bio-
markers in pain conditions should be performed.
In our study, the time of sample collection varied since
depended of when the veterinarian attended the emer-
gency case. Although ideally, in order to avoid circadian
rhythms, sampling should have been always made at the
same time, this was not possible from a practical point
of view since the priority was to explore and attend the
horses as soon as possible. In any case, although there is
no data in horses about circadian rhythms of sAA, if we
consider the data reported in humans [37] with a max-
imum of 1.76 fold of increase from basal time at 9:00 to
the peak which was found 16:00, this would not have a
major influence in the differences obtained in our study,
since median values in the clinical cases were 24.5-fold
higher in healthy horses. Regarding the salivary cortisol,
it has demonstrated an acrophase at 10:00 in horses [38]
with a difference only of 0.03 μg/dL between 10:00 at 22:
00 which is much lower than the median difference found
in our study between the two groups of horses (0.3 μg/dL).
Although the statistical analysis confirmed that the
number of horses used in our study was enough to
Table 2 Salivary alpha-amylase (sAA, n = 19) and salivary cortisol (n = 16) coefficients of correlation between Equine acute abdominal
pain scales-version 1 (EAAPS-1), heart rate (HR) and respiratory rate (RR), plasma lactate, systemic inflammatory response syndrome
(SIRS) score and Serum Amyloid A (SAA)
sAA (U/L) P values Salivary cortisol (μg/dL) P values
EAAPS-1 score 0.78 (0.38, 0.89) < 0.001 0.11 (−0.42, 0.58) 0.685
HR (beats/min) 0.22 (−0.27, 0.62) 0.362 0.24 (−0.31, 0.67) 0.370
RR (breaths/min) 0.32 (−0.17, 0.68) 0.184 0.26 (−0.28, 0.68) 0.320
SAA (μg/mL) 0.29 (−0.21, 0.67) 0.235 −0.08 (− 0.54, 0.42) 0.761
Plasma lactate (mmol/L) 0.44 (−0.05, 0.76) 0.069 0.17 (−0.38, 0.64) 0.532
SIRS score 0.49 (0.03, 0.78) 0.032 0.16 (−0.38, 0.62) 0.560
Results are expressed as Spearman r-value (95% confidence interval [CI]). SIRS score (4 point-score) is based on the number of abnormal SIRS criteria among the
following: HR > 52 beats/min, RR > 20 breath/min, WBC above or below 5.0–12.5 × 109/L, and temperature below or above 37.0–38.5 °C
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evaluate differences between clinical and control horses,
further studies involving a larger number of horses with
acute abdominal disease would be recommended in
order to confirm the relationship between sAA and pain.
It is important to point out that pain evaluation do not
replaces clinical decision making (which is made based
on physical examination, blood results, ultrasound, and
other diagnostic tests), but its objective evaluation by
biomarkers could help to better evaluate the patient at
admission and also to improve the follow-up during the
treatment. In addition, it could have importance as a
prognostic factor for the severity of colic [1]. Overall,
this study should be expanded using a larger population
to assess possible differences in the biomarkers depend-
ing of the origin of the acute abdominal disease and to
evaluate the possible use of sAA and cortisol as a prog-
nostic factor since the two highest sAA values were pre-
sented in the two no-survivor horses. In addition, it
would be of interest to analyze a population of horses
admitted to a hospital for non-painful, elective proce-
dures to investigate the effect of other variables that
cause stress for horses, such as transport and arrival to
an unfamiliar facility, in the salivary biomarkers asses-
sing in this study. Eventually, these studies could even
lead to include sAA in future pain scales as a pain-
induced stress biomarker.
Conclusion
This study reports an increase of alpha-amylase activity
in saliva of horses with acute abdominal disease, and it
is correlated with EAPPS-1 pain scale. These preliminary
results indicate that sAA could potentially be a bio-
marker of pain-induced stress in cases of horses with
acute abdominal disease.
Additional file
Additional file 1: Individuals values of heart rate (HR), respiratory rate
(RR), white blood cell (WBC), temperature and systemic inflammatory
response syndrome (SIRS) score in the disease horses (n= 19). Individuals
values about data required for the SIRS score calculation (HR, RR, temperature
and WBC) in the disease horses. SIRS state is defined as having two or more
abnormal results for any of the following: HR > 52 beats/min, RR > 20 breath
/min, WBC above or below 5.0–12.5 × 109/L, and temperature below or
above 37.0–38.5 °C. SIRS score is obtained on the number of abnormal SIRS
criteria (4 point-score). non-SIRS: 0–1 abnormal criteria; SIRS2: 2 abnormal SIRS
criteria; SIRS3/4: 3 or 4 abnormal SIRS criteria [12]. (XLSX 41 kb)
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